Product Information
AMOXICILLIN 125 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0176 per ML under NDC 65862070655. Its NADAC has been published 482 times since Sep 9, 2015.
FDA first approved this application on Sep 15, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862070655
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA204030FDA Approved
9/15/2014
TE Code
AB
On Market Since
9/15/2014
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 125 MG/5 ML SUSP has been published 482 times since Sep 9, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0176 per ML |
|---|---|
| All-time high | $0.0210 (Dec 13, 2023) |
| All-time low | $0.0137 (Jul 19, 2023) |
| 52-week high | $0.0193 |
| 52-week low | $0.0176 |
| Median price | $0.0174 |
| Average price | $0.0172 |
| Largest weekly change | +37.0% (Aug 23, 2023) |
| Weeks tracked | 482 |
| Tracking since | Sep 9, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 125 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.0176 per ML (NDC 65862070655), effective Sep 30, 2026.
How has the price of AMOXICILLIN 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 125 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 482 weekly CMS publications since Sep 9, 2015.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 125 MG/5 ML SUSP?
Since Sep 9, 2015, the NADAC for AMOXICILLIN 125 MG/5 ML SUSP has ranged from a low of $0.0137 (Jul 19, 2023) to a high of $0.0210 (Dec 13, 2023), with a median of $0.0174 per ML.
Are there cheaper alternatives to AMOXICILLIN 125 MG/5 ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMOXICILLIN 125 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOXICILLIN 125 MG/5 ML SUSP?
AMOXICILLIN 125 MG/5 ML SUSP (NDC 65862070655) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.